دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S1542-3565(23)01011-X
Volume 22, Issue 2, February 2024, Pages A11-A13
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)01012-1
Volume 22, Issue 2, February 2024, Pages A15-A16
Natural Evolution of Pancreatic Serous Cystadenoma on Endoscopic Ultrasound
Mehdi Mohamadnejad, 1 Arash Nikmanesh, 1,2 and Mohamad Eloubeidi
doi : 10.1016/j.cgh.2023.08.014
Volume 22, Issue 2, February 2024, Pages A25-A26
Pinstripe Pattern of Esophageal Achalasia Demonstrated With Texture and Color Enhancement Imaging
Yugo Iwaya, 1 Takuma Okamura, 1 and Tadanobu Nagaya
doi : 10.1016/j.cgh.2023.08.025
Volume 22, Issue 2, February 2024, Page A27
Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma With Varices Using Red Dichromatic Imaging
Tomoya Ueda, 1 Takashi Kanesaka, 1,2 and Ryu Ishihara
doi : 10.1016/j.cgh.2023.08.036
Volume 22, Issue 2, February 2024, Pages A31-A32
Blue Notes
CHARLES J. KAHI, MD, MS, AGAF
doi : 10.1016/j.cgh.2023.11.019
Volume 22, Issue 2, February 2024, Pages 207-208
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases
BHARATI KOCHAR ASHWIN N. ANANTHAKRISHNAN
doi : 10.1016/j.cgh.2023.11.012
Volume 22, Issue 2, February 2024, Pages 209-214
Metabolic Dysfunction–Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Proposed Stepwise Approach
Metabolic Dysfunction–Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Proposed Stepwise Approach
doi : 10.1016/j.cgh.2023.08.019
Volume 22, Issue 2, February 2024, Pages 215-218
Developing a Gastroenterology Career in Quality
Arun B. Jesudian
doi : 10.1016/j.cgh.2023.10.002
Volume 22, Issue 2, February 2024, Pages 219-221
Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome
Darren M. Brenner, 1 Amy M. Ladewski, 2 and Sarah Wimberly Kinsinger
doi : 10.1016/j.cgh.2023.09.013
Volume 22, Issue 2, February 2024, Pages 222-234
Is it Time for the Alternative to Move to the Mainstream?
ASHWIN N. ANANTHAKRISHNAN
doi : 10.1016/j.cgh.2023.07.003
Volume 22, Issue 2, February 2024, Pages 235-236
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?
MAURA CORSETTI
doi : 10.1016/j.cgh.2023.04.032
Volume 22, Issue 2, February 2024, Pages 237-240
Exploring the Small Intestinal Microbiome: Relationships to Symptoms and Small Intestinal Bacterial Overgrowth
EAMONN M. M. QUIGLEY
doi : 10.1016/j.cgh.2023.09.025
Volume 22, Issue 2, February 2024, Pages 241-242
Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome
Vivek C. Goodoory, 1,2 Ashok K. Tuteja, 3,4 Christopher J. Black, 1,2 and Alexander C. Ford
doi : 10.1016/j.cgh.2023.02.014
Volume 22, Issue 2, February 2024, Pages 243-251.e5
Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis
Christopher J. Lee1 and Evan S. Dellon
doi : 10.1016/j.cgh.2023.08.015
Volume 22, Issue 2, February 2024, Pages 252-258
Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing
Gabriela Leite, 1 Ali Rezaie, 1,2 Ruchi Mathur, 1,3 Gillian M. Barlow, 1 Mohamad Rashid, 1 Ava Hosseini, 1 Jiajing Wang, 1 Gonzalo Parodi, 1 Maria Jesus Villanueva-Millan, 1 Maritza Sanchez, 1 Walter Morales, 1 Stacy Weitsman,1 Mark Pimentel, 1,2 and the REIMAGINE Study Group
doi : 10.1016/j.cgh.2023.06.001
Volume 22, Issue 2, February 2024, Pages 259-270
An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan
Naohisa Yoshida, 1 Yoshikazu Hayashi, 2 Daichi Togo, 3 Shiro Oka, 4 Kazunori Takada, 5 Shusei Fukunaga, 6 Yoshinori Morita, 7 Takemasa Hayashi, 8 Kazuhiro Kozuka, 9 Yosuke Tsuji, 10 Takashi Murakami, 11 Takeshi Yamamura, 12 Yoriaki Komeda, 13 Yoji Takeuchi,14 Kensuke Shinmura, 15 Hiroko Fukuda, 16 Shinji Yoshii, 17 Shoko Ono, 18 Shinichi Katsuki, 19 Kazumasa Kawashima, 20 Daiki Nemoto, 21 Hiroyuki Yamamoto, 22 Yutaka Saito, 23 Naoto Tamai, 24 Aya Iwao, 25 Yuki Itoi, 26 Shigetsugu Tsuji, 27 Yoshikazu Inagaki, 28 Yutaka Inada, 29 Koichi Soga, 30 Daisuke Hasegawa,31 Takaaki Murakami, 32 Hiroyuki Yoriki, 33 Kohei Fukumoto, 34 Takayuki Motoyoshi, 35 Yasuki Nakatani, 36 Yasushi Sano, 37 Mikitaka Iguchi, 38 Shigehiko Fujii, 39 Hiromitsu Ban, 40 Keita Harada, 41 Koichi Okamoto, 42 Hitoshi Nishiyama, 43 Fumisato Sasaki, 44 Kazujhiro Mizukami, 45 Takashi Shono, 46 Ryo Shimoda, 47 Tadashi Miike, 48 and Naoyuki Yamaguchi
doi : 10.1016/j.cgh.2023.09.012
Volume 22, Issue 2, February 2024, Pages 271-282.e3
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)
Malin Fromme, 1, * Karim Hamesch,1, * Carolin V. Schneider, 1 Mattias Mandorfer, 2 Monica Pons, 3,4 Katrine H. Thorhauge, 5,6 Vitor Pereira, 7 Jan Sperl, 8 Sona Frankova, 8 Matthias C. Reichert, 9 Federica Benini, 10 Barbara Burbaum, 1 Moritz Kleinjans,1 Samira Amzou,1 Laura Rademacher, 1 Lisa Bewersdorf, 1 Jef Verbeek, 11 Frederik Nevens, 11 Joan Genesca, 3,4 Marc Miravitlles, 12 Alexa Nu?ez, 12 Benedikt Schaefer, 13 Heinz Zoller, 13 Sabina Janciauskiene,14 Johan Waern, 15 Ant?nio Oliveira, 7 Lu?s Maia, 16 Carolina Sim?es, 17 Ravi Mahadeva, 18 Daniel D. Fraughen, 19 Michael Trauner, 2 Aleksander Krag, 5,6 Frank Lammert, 9,20 Robert Bals,21 Nadine T. Gaisa, 22 Elmar Aigner, 23 William J. Griffiths, 24 Helmut Denk, 25 Alexander Teumer, 26,27 Noel G. McElvaney,19 Alice M. Turner, 28 Christian Trautwein, 1 and Pavel Strnad
doi : 10.1016/j.cgh.2023.08.038
Volume 22, Issue 2, February 2024, Pages 283-294.e5
Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis
Darine Daher, 1 Karim Seif El Dahan, 1 Alva Cano, 1 Michael Gonzales, 1 Crystal Ransom, 1 Erik Jaurez, 1 Osiris Carranza, 1 Lisa Quirk, 1 Todd Morgan, 1 Purva Gopal, 1 Madhukar S. Patel, 2 Sarah Lieber, 1 Jeremy Louissaint, 1 Thomas G. Cotter, 1 Lisa B. VanWagner, 1 Ju Dong Yang, 3 Neehar D. Parikh, 4 Adam Yopp, 2 Nicole E. Rich, 1 and Amit G. Singal
doi : 10.1016/j.cgh.2023.08.003
Volume 22, Issue 2, February 2024, Pages 295-304.e2
Age-Dependent Female Survival Advantage in Hepatocellular Carcinoma: A Multicenter Cohort Study
Chuan Pang, 1,2 Jian-Ming Li, 1 Zhen Wang, 1 Yan-Chun Luo, 1 Zhi-Gang Cheng, 1 Zhi-Yu Han, 1 Fang-Yi Liu, 1 Xiao-Ling Yu, 1 Feng Liang, 2 Hong-Qing Xi, 2 Rong-Qin Zheng, 3 Wen Cheng, 4 Qiang Wei, 5 Song-Yuan Yu, 6 Qin-Ying Li, 7 Guang-Zhi He, 8 Jie Yu,1 and Ping Liang
doi : 10.1016/j.cgh.2023.07.029
Volume 22, Issue 2, February 2024, Pages 305-314
Association of Renin-Angiotensin System Inhibition With Liver-Related Events and Mortality in Compensated Cirrhosis
Hirsh Elhence, 1 Jennifer L. Dodge, 2,3 and Brian P. Lee
doi : 10.1016/j.cgh.2023.07.009
Volume 22, Issue 2, February 2024, Pages 315-323.e17
Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project
Shari S. Rogal,1,2,3 Tamar H. Taddei,4,5 Alexander Monto,6 Vera Yakovchenko,1 Heather Patton,7 Monica Merante,1 Patrick Spoutz,8 Linda Chia,8 Jennifer Yudkevich,9 Ayse Aytaman,9,10 Atoosa Rabiee,11 Binu V. John,12,13 Boris Blechacz,14 Cindy X. Cai,15,16,17 HoChong Gilles,18 Anand S. Shah,19,20 Heather McCurdy,21 Puneet Puri,18,22 Janice Jou,23,24 Khurram Mazhar,25,26 Jason A. Dominitz,27,28 Jennifer Anwar,29 Timothy R. Morgan,29,30 and George N. Ioannou
doi : 10.1016/j.cgh.2023.07.002
Volume 22, Issue 2, February 2024, Pages 324-338
Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women
Stephanie S. Maldonado, 1 Marcelle I. Cedars, 2 Katherine P. Yates, 3 Laura A. Wilson, 3 Ryan Gill, 4 Norah A. Terrault, 5 Ayako Suzuki, 6 and Monika A. Sarkar
doi : 10.1016/j.cgh.2023.08.020
Volume 22, Issue 2, February 2024, Pages 339-346.e5
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial
Shomron Ben-Horin, 1,2 Nir Salomon, 1 Georgios Karampekos, 3 Nikos Viazis, 3 Adi Lahat, 1,2 Bella Ungar, 1,2 Rami Eliakim, 1,2 Rafael Kuperstein, 2,4 Ofra Kriger-Sharabi, 5 Hilla Reiss-Mintz, 6 Henit Yanai, 2,7 Iris Dotan,2,7 Eran Zittan, 8,9 Nitsan Maharshak, 2,10 Ayal Hirsch, 2,10 Michal Weitman, 11 Gerassimos J. Mantzaris,3 and Uri Kopylov
doi : 10.1016/j.cgh.2023.05.023
Volume 22, Issue 2, February 2024, Pages 347-356.e6
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study
Maarten te Groen, 1, * Monica Derks, 1, * Nathan den Broeder, 1 Charlotte Peters, 2 Gerard Dijkstra, 3 Annemarie de Vries, 4 Tessa Romkens, 5 Carmen Horjus, 6 Nanne de Boer, 7 Michiel de Jong, 1 Iris Nagtegaal, 8 Lauranne Derikx, 1,4,‡ and Frank Hoentjen
doi : 10.1016/j.cgh.2022.12.010
Volume 22, Issue 2, February 2024, Pages 357-367.e5
Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization
Duke Geem, 1,2 David Hercules, 1 Ranjit S. Pelia, 1 Suresh Venkateswaran, 1 Anne Griffiths, 3 Joshua D. Noe, 4 Jennifer L. Dotson, 5 Scott Snapper, 6 Shervin Rabizadeh, 7 Joel R. Rosh, 8 Robert N. Baldassano, 9 James F. Markowitz, 10 Thomas D. Walters, 3 Ashwin Ananthakrishnan, 11 Garima Sharma, 1 Lee A. Denson, 12,§ Jeffrey S. Hyams, 13,§ and Subra Kugathasan
doi : 10.1016/j.cgh.2023.08.042
Volume 22, Issue 2, February 2024, Pages 368-376.e4
Comparative Effectiveness of Biologic Therapies in Preventing Penetrating Complications in Patients With Crohn’s Disease
Jeffrey D. McCurdy, 1,2 Dustin Stwalley, 3 Margaret A. Olsen, 3 and Parakkal Deepak
doi : 10.1016/j.cgh.2023.08.017
Volume 22, Issue 2, February 2024, Pages 377-385.e5
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden
Christopher J. Black, 1,2 Cho-Ee Ng, 3 Vivek C. Goodoory, 1,2,§ and Alexander C. Ford
doi : 10.1016/j.cgh.2023.02.016
Volume 22, Issue 2, February 2024, Pages 386-396.e10
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document
Darren M. Brenner, 1 Maura Corsetti, 2 Douglas Drossman,3 Jan Tack, 4 and Arnold Wald
doi : 10.1016/j.cgh.2023.08.044
Volume 22, Issue 2, February 2024, Pages 397-412
Longer Breastfeeding Duration Is Associated With Decreased Risk of Hepatic Fibrosis Among Young Women With Nonalcoholic Fatty Liver Disease
GEORGIA SOFIA KARACHALIOU AYAKO SUZUKIVAISHALI A. PATELLORI A. BASTIANANNA MAE DIEHLMANAL F. ABDELMALEK
doi : 10.1016/j.cgh.2023.05.027
Volume 22, Issue 2, February 2024, Pages 413-415.e3
Declines in Colorectal Cancer Incidence and Mortality Rates Slow Among Older Adults
CAITLIN C. MURPHYJEFFREY K. LEEPETER S. LIANGFOLASADE P. MAYTIMOTHY A. ZAKI
doi : 10.1016/j.cgh.2023.05.033
Volume 22, Issue 2, February 2024, Pages 416-419.e5
Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not Enough
SEAN L. LAPPMEENAKSHI BEWTRA JAMES D. LEWIS
doi : 10.1016/j.cgh.2023.06.003
Volume 22, Issue 2, February 2024, Pages 420-422.e2
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey
BRAD D. CONSTANT LINDSEY ALBENBERG ELANA B. MITCHELEDWIN F. DE ZOETENJUSTIN T. CLAPPFRANK I. SCOTT
doi : 10.1016/j.cgh.2023.06.021
Volume 22, Issue 2, February 2024, Pages 423-426
High Use of Estrogen-based Contraceptives in Young Women With Inflammatory Bowel Disease in the United States
ERICA J. BRENNERXIAN ZHANGMILLIE D. LONGMARLA C. DUBINSKYMICHAEL D. KAPPELMAN
doi : 10.1016/j.cgh.2023.07.007
Volume 22, Issue 2, February 2024, Pages 427-429.e28
Population-Attributable Fractions of Nonalcoholic Fatty Liver Disease on All-Cause and Cause-Specific Mortality Risk: How Large is the Impact?
LIN QIN KEWEI ZHANGJIARONG XIE
doi : 10.1016/j.cgh.2023.04.021
Volume 22, Issue 2, February 2024, Page 430
Targeting Colorectal Advanced Neoplasia in Asia-Pacific or Locally: Why the Score Name Matters
FAN YANG DAN MA
doi : 10.1016/j.cgh.2023.05.015
Volume 22, Issue 2, February 2024, Pages 432-433
Beyond One-Size-Fits-All: Size-Oriented Criteria for the Step-Up Treatment of Walled-Off Pancreatic Necrosis
TSUYOSHI HAMADAMASAHIRO TSUJIMAEYOUSUKE NAKAI
doi : 10.1016/j.cgh.2023.05.026
Volume 22, Issue 2, February 2024, Pages 433-435
Reply
SERGE BAROUDFATEH BAZERBACHIBARHAM K. ABU DAYYEH
doi : 10.1016/j.cgh.2023.06.028
Volume 22, Issue 2, February 2024, Page 435
Hepatorenal Syndrome-Acute Kidney Injury Definition Needs a Minimum Threshold for Serum Creatinine
PAUL J. THULUVATH
doi : 10.1016/j.cgh.2023.05.009
Volume 22, Issue 2, February 2024, Pages 435-436
Reply
STEVEN L. FLAMMFLORENCE WONGJOSEPH AHNPATRICK S. KAMATH
doi : 10.1016/j.cgh.2023.07.022
Volume 22, Issue 2, February 2024, Pages 436-437
